Search clinical trials for: CD38-SADA:177Lu-DOTA Complex
Total 108 results
-
Y-mAbs TherapeuticsNot yet recruiting
-
Y-mAbs TherapeuticsRecruitingSarcoma | SCLC | Malignant MelanomaUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruiting177Lu-DOTA-FAPI | 68Ga-DOTA-FAPI | TheranosticChina
-
Telix International Pty LtdNot yet recruiting
-
The First Affiliated Hospital of Xiamen UniversityRecruitingRefractory Solid TumorChina
-
University of California, DavisNational Institutes of Health (NIH)RecruitingMetastatic CancerUnited States
-
Instituto Nacional de Cancerologia, ColumbiaCompleted
-
Peking Union Medical College HospitalRecruitingNeuroendocrine TumorsChina
-
University of California, DavisUnited States Department of DefenseRecruitingMetastatic Nonsmall Cell Lung CancerUnited States
-
Telix Pharmaceuticals (Innovations) Pty LimitedActive, not recruiting
-
Telix International Pty LtdCompletedMetastatic Prostate CancerAustralia
-
University of California, DavisRecruitingLocally Advanced Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States
-
Assiut UniversityNot yet recruitingITP - Immune Thrombocytopenia
-
The First Affiliated Hospital of Xiamen UniversityRecruitingRefractory Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell CarcinomaChina
-
Y-mAbs TherapeuticsWithdrawnSolid Tumor, Adult | Leptomeningeal MetastasisUnited States, United Kingdom
-
CHU de Quebec-Universite LavalRecruitingNeuroendocrine Tumors | Carcinoma, Neuroendocrine | Carcinoid TumorCanada
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Unknown
-
Stanford UniversityPatient-Centered Outcomes Research Institute; San Mateo Medical CenterRecruiting
-
OHSU Knight Cancer InstituteNovartis; Oregon Health and Science UniversityNot yet recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMetastatic Adrenal Gland Pheochromocytoma | Stage III Thyroid Gland Medullary Carcinoma AJCC v8 | Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 | Locally Advanced Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Metastatic Parathyroid Gland Carcinoma and other conditionsUnited States
-
Telix Pharmaceuticals (Innovations) Pty LimitedMerck KGaA, Darmstadt, GermanyRecruitingAdvanced Solid Tumor | Solid Tumor, Adult | Advanced Renal Cell CarcinomaAustralia
-
Lund University HospitalCompletedNeuroendocrine Tumors | Liver MetastasesSweden
-
Memorial Sloan Kettering Cancer CenterCompletedNeuroendocrine TumorsUnited States
-
University Hospital, Basel, SwitzerlandAda Health GmbHCompleted
-
University Hospital, Basel, SwitzerlandSwiss Cancer LeagueRecruiting
-
Novartis PharmaceuticalsRecruitingGlioblastomaSpain, Switzerland, France, Portugal, United States
-
Molecular Targeting Technologies, Inc.ClinSmartRecruitingNeuroendocrine TumorsUnited States
-
Peking UniversityNot yet recruiting
-
Peter MacCallum Cancer Centre, AustraliaRecruitingNeuroendocrine TumorsAustralia
-
Novartis PharmaceuticalsNot yet recruitingMetastatic Neuroendocrine Prostate Cancer
-
Sue O'DorisioAdvanced Accelerator ApplicationsWithdrawnNeuroendocrine Tumors | Pheochromocytoma | ParagangliomaUnited States
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Paul Scherrer Institute (PSI)RecruitingNeuroendocrine Neoplasia's (NENs) | Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)Switzerland
-
Advanced Accelerator ApplicationsApproved for marketingNeuroendocrine TumorsUnited States
-
Nordic NanovectorWithdrawnNon-Hodgkin LymphomaGermany
-
Novartis PharmaceuticalsRecruitingExtensive Stage Small Cell Lung CancerGermany, Spain, United States, France, United Kingdom
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Completed
-
Sinotau Pharmaceutical GroupRecruiting
-
Vastra Gotaland RegionAdvanced Accelerator ApplicationsActive, not recruitingThymoma | Neuroendocrine Tumors | Mesothelioma | Clinical Trial, Phase ISweden
-
Istituto Scientifico Romagnolo per lo Studio e...Not yet recruiting
-
University Hospital Schleswig-HolsteinCompletedSafety Issues | PharmacokineticGermany
-
University of California, Los AngelesRecruitingAdenosine Deaminase Severe Combined Immune DeficiencyUnited States
-
University Hospital Schleswig-HolsteinRecruiting
-
National Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
University of California, Los AngelesOrchard Therapeutics; California Institute for Regenerative Medicine (CIRM)CompletedSevere Combined Immunodeficiency Due to ADA DeficiencyUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Emory UniversityChildren's Research Oversight Committee FundsCompletedCardiopulmonary BypassUnited States
-
Advanced Accelerator ApplicationsCompletedCarcinoid Tumor of the Small Bowel | Neuroendocrine TumourUnited States, United Kingdom, Italy, Belgium, France, Germany, Portugal, Spain
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID); National Heart... and other collaboratorsCompleted
-
Great Ormond Street Hospital for Children NHS Foundation...Orchard TherapeuticsCompletedAdenosine Deaminase Deficiency | Severe Combined Immunodeficiencies (SCID)United Kingdom